Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 11Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 8Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Etoposide 4Daunorubicin 4Radiotherapy 3Mitoxantrone 3Filgrastim 3Cyclophosphamide 3lintuzumab 2Microarray Analysis 2Busulfan 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Tretinoin 1Thioguanine 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Mesna 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1DNA Methylation 1Clofarabine 1Base Sequence 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Erythroblastic, Acute × Gemtuzumab × Clear all
NCT00091234 2012-07-24

AML-19

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
279 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡